Status:
COMPLETED
Segment IV Hypertrophy After Liver Venous Deprivation
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Major Hepatectomy
Eligibility:
All Genders
18-100 years
Brief Summary
before major hepatectomy, in case of insufisant future liver remanent volume or function, portal embolization is a routinely used method to enable growth of the future liver remnant. Recently liver ve...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- \- patient with liver tumor selected for right hepatectomy with insufficient future liver remnant who have undergoes portal embolization or liver venous deprivation
- Exclusion criteria:
- \- left / extended left hepatectomy
Exclusion
Key Trial Info
Start Date :
January 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 15 2020
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04370132
Start Date
January 1 2015
End Date
April 15 2020
Last Update
April 30 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uh Montpellier
Montpellier, France, 34295